Gain Therapeutics Inc (GANX) — Defensive Interval Ratio
Gain Therapeutics Inc (GANX) has a Defensive Interval Ratio of 87 days as of December 2025. Defensive assets of $802.69K (cash $-, short-term investments $-, receivables $802.69K) cover 87 days of daily cash needs of $9.18K/day. Check Gain Therapeutics Inc (GANX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Gain Therapeutics Inc Defensive Interval Ratio (2018–2025)
This chart shows how Gain Therapeutics Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the ratio stands at 87 days, meaning defensive assets of $802.69K can fund 87 days of operations without new revenue. Also explore net asset growth rate of Gain Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Gain Therapeutics Inc (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Gain Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see GANX stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 87 days | $802.69K | $9.18K/day | $- | $- | ▲ +16 days |
| 2024 | 71 days | $765.76K | $10.72K/day | $- | $0.00 | ▼ -315 days |
| 2023 | 387 days | $5.24 Million | $13.56K/day | $- | $5.00 Million | ▼ -758 days |
| 2022 | 1144 days | $12.93 Million | $11.30K/day | $- | $12.83 Million | ▲ +1116 days |
| 2021 | 28 days | $195.45K | $6.99K/day | $- | $0.00 | ▲ +26 days |
| 2020 | 1 days | $8.55K | $5.79K/day | $- | $- | ▼ -17 days |
| 2019 | 19 days | $44.91K | $2.41K/day | $- | $- | ▼ -10 days |
| 2018 | 29 days | $41.79K | $1.45K/day | $- | $- | — |